These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 19808298)

  • 41. Dietary inflammatory index, cardiometabolic conditions and depression in the Seguimiento Universidad de Navarra cohort study.
    Sánchez-Villegas A; Ruíz-Canela M; de la Fuente-Arrillaga C; Gea A; Shivappa N; Hébert JR; Martínez-González MA
    Br J Nutr; 2015 Nov; 114(9):1471-9. PubMed ID: 26344165
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The influence of cardiac rehabilitation on inflammation and metabolic syndrome in women with coronary heart disease.
    Beckie TM; Beckstead JW; Groer MW
    J Cardiovasc Nurs; 2010; 25(1):52-60. PubMed ID: 19935427
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Asymptomatic hyperuricemia and incident congestive heart failure in elderly patients without comorbidities.
    Wu X; Jian G; Tang Y; Cheng H; Wang N; Wu J
    Nutr Metab Cardiovasc Dis; 2020 Apr; 30(4):666-673. PubMed ID: 32127333
    [TBL] [Abstract][Full Text] [Related]  

  • 44. C-reactive protein, the metabolic syndrome, and risk of incident cardiovascular events: an 8-year follow-up of 14 719 initially healthy American women.
    Ridker PM; Buring JE; Cook NR; Rifai N
    Circulation; 2003 Jan; 107(3):391-7. PubMed ID: 12551861
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Inflammatory markers as related to disease severity in patients with chronic heart failure: limited effects of exercise training.
    Byrkjeland R; Nilsson BB; Westheim AS; Arnesen H; Seljeflot I
    Scand J Clin Lab Invest; 2011 Nov; 71(7):598-605. PubMed ID: 21831004
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Inflammations mediators and circulating levels of matrix metalloproteinases: Biomarkers of diabetes in Tunisians metabolic syndrome patients.
    Zayani Y; El Golli N; Zidi W; Guizani I; Boussairi S; Aloui S; Ayadi I; Ftouhi B; Feki M; Ben Romdhane N; Ben Sliman H; Allal-Elasmi M; Kaabachi N
    Cytokine; 2016 Oct; 86():47-52. PubMed ID: 27455450
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Prospective study of metabolic syndrome as a mortality marker in chronic coronary heart disease patients.
    Mayer O; Bruthans J; Seidlerová J; Karnosová P; Vaněk J; Hronová M; Gelžinský J; Cvíčela M; Wohlfahrt P; Cífková R; Filipovský J
    Eur J Intern Med; 2018 Jan; 47():55-61. PubMed ID: 28755847
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Aldosterone, C-reactive protein, and plasma B-type natriuretic peptide are associated with the development of metabolic syndrome and longitudinal changes in metabolic syndrome components: findings from the Jackson Heart Study.
    Musani SK; Vasan RS; Bidulescu A; Liu J; Xanthakis V; Sims M; Gawalapu RK; Samdarshi TE; Steffes M; Taylor HA; Fox ER
    Diabetes Care; 2013 Oct; 36(10):3084-92. PubMed ID: 23757435
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Risk for cardiovascular disease associated with metabolic syndrome and its components: a 13-year prospective study in the RIVANA cohort.
    Guembe MJ; Fernandez-Lazaro CI; Sayon-Orea C; Toledo E; Moreno-Iribas C;
    Cardiovasc Diabetol; 2020 Nov; 19(1):195. PubMed ID: 33222691
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Metabolic syndrome, inflammation, and nonamnestic mild cognitive impairment in older persons: a population-based study.
    Roberts RO; Geda YE; Knopman DS; Cha RH; Boeve BF; Ivnik RJ; Pankratz VS; Tangalos EG; Petersen RC
    Alzheimer Dis Assoc Disord; 2010; 24(1):11-8. PubMed ID: 19568151
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Multimarker Assessment of Diastolic Dysfunction in Metabolic Syndrome Patients.
    Mocan M; Anton F; Suciu Ș; Răhăian R; Blaga SN; Fărcaș AD
    Metab Syndr Relat Disord; 2017 Dec; 15(10):507-514. PubMed ID: 29099655
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Sex differences in the prediction of type 2 diabetes by inflammatory markers: results from the MONICA/KORA Augsburg case-cohort study, 1984-2002.
    Thorand B; Baumert J; Kolb H; Meisinger C; Chambless L; Koenig W; Herder C
    Diabetes Care; 2007 Apr; 30(4):854-60. PubMed ID: 17392546
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Inflammation, obesity, and metabolic syndrome in depression: analysis of the 2009-2010 National Health and Nutrition Examination Survey (NHANES).
    Rethorst CD; Bernstein I; Trivedi MH
    J Clin Psychiatry; 2014 Dec; 75(12):e1428-32. PubMed ID: 25551239
    [TBL] [Abstract][Full Text] [Related]  

  • 54. M-mode echocardiographic predictors of six- to seven-year incidence of coronary heart disease, stroke, congestive heart failure, and mortality in an elderly cohort (the Cardiovascular Health Study).
    Gardin JM; McClelland R; Kitzman D; Lima JA; Bommer W; Klopfenstein HS; Wong ND; Smith VE; Gottdiener J
    Am J Cardiol; 2001 May; 87(9):1051-7. PubMed ID: 11348601
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Six-year change in high-sensitivity C-reactive protein and risk of diabetes, cardiovascular disease, and mortality.
    Parrinello CM; Lutsey PL; Ballantyne CM; Folsom AR; Pankow JS; Selvin E
    Am Heart J; 2015 Aug; 170(2):380-9. PubMed ID: 26299237
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cardiovascular death and the metabolic syndrome: role of adiposity-signaling hormones and inflammatory markers.
    Langenberg C; Bergstrom J; Scheidt-Nave C; Pfeilschifter J; Barrett-Connor E
    Diabetes Care; 2006 Jun; 29(6):1363-9. PubMed ID: 16732022
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Association of C-reactive protein with reduced forced vital capacity in a nonsmoking U.S. population with metabolic syndrome and diabetes.
    Lee HM; Le TV; Lopez VA; Wong ND
    Diabetes Care; 2008 Oct; 31(10):2000-2. PubMed ID: 18591402
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Metabolic syndrome and incident peripheral artery disease - the Multi-Ethnic Study of Atherosclerosis.
    Vidula H; Liu K; Criqui MH; Szklo M; Allison M; Sibley C; Ouyang P; Tracy RP; Chan C; McDermott MM
    Atherosclerosis; 2015 Nov; 243(1):198-203. PubMed ID: 26398292
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Inflammation and future risk of symptomatic heart failure in patients with stable coronary artery disease.
    Eisen A; Benderly M; Behar S; Goldbourt U; Haim M
    Am Heart J; 2014 May; 167(5):707-14. PubMed ID: 24766981
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Do albuminuria and hs-CRP add to the International Diabetes Federation definition of the metabolic syndrome in predicting outcome?
    van der Velde M; Bello AK; Brantsma AH; El Nahas M; Bakker SJ; de Jong PE; Gansevoort RT
    Nephrol Dial Transplant; 2012 Jun; 27(6):2275-83. PubMed ID: 22231032
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.